-
A total of 1,763 HIV-1 serodiscordant couples in nine countries with the infected partner having CD4+ counts of 350-500/mL were randomized 1:1 to early (immediate) vs. delayed (CD4+ had declined to ¡Ü 250/mL or after development of an AIDS-related illness) antiretroviral therapy of the infected partner.
-
With the Centers for Disease Control and Prevention's (CDC's) new HIV prevention focus on scientifically proven, cost-effective, and scalable interventions targeted to the right populations, some experts worry black women will be left a low priority on the formula. And federal funding for small, hands-on prevention programs that work holistically with women of color might dry up entirely.
-
A California-based company is looking at new condom designs, including a male non-rolled silicone condom, a female silicone condom, and a silicone condom designed specifically for receptive anal intercourse. All three designs of Origami condoms are in early research stages at Culver City, CA-based Strata Various Product Designs.
-
On Aug. 10, 2011, the Food and Drug Administration (FDA) approved Complera, a fixed dose combination (FDC) drug product containing emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF) for the treatment of HIV. The recommended dose of Complera is one tablet, containing 200mg/25mg/300mg of FTC/RPV/TDF, once daily, taken orally with a meal.
-
The Joint Commission recently posted the following answer to a frequently asked question on screening for methicillin-resistant Staphylococcus aureus (MRSA).
-
The elements of performance for the CAUTI prevention safety goal are as follows:
-
The Joint Commission's new National Patient Safety Goal (NPSG) on preventing indwelling catheter-associated urinary tract infections which emphasizes prompt removal of unnecessary devices and surveillance for CAUTIs is effective January 1, 2012 for hospitals.
-
Field test results of an integrated microfluidic-based diagnostic device indicate that the potential
-
African-American girls from low-income neighborhoods who have had childhood violence exposure are significantly more likely to engage in high-risk sexual activities, researchers found.
-
New research suggests that roughly half of HIV patients might have some neurocognitive impairment, although most of this might be asymptomatic or mild.